Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors

P Jagtap, C Szabó - Nature reviews Drug discovery, 2005 - nature.com
Abstract Poly (ADP-ribose) polymerases (PARPs) are involved in the regulation of many
cellular functions. Three consequences of the activation of PARP1, which is the main isoform …

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases

A Peralta-Leal, JM Rodríguez-Vargas… - Free Radical Biology …, 2009 - Elsevier
Poly (ADP-ribose) polymerases (PARPs) are defined as cell signaling enzymes that catalyze
the transfer of ADP-ribose units from NAD+ to a number of acceptor proteins. PARP-1, the …

Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

E Wahlberg, T Karlberg, E Kouznetsova… - Nature …, 2012 - nature.com
Inhibitors of poly-ADP-ribose polymerase (PARP) family proteins are currently in clinical
trials as cancer therapeutics, yet the specificity of many of these compounds is unknown …

Nuclear poly (ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

L McGurk, J Mojsilovic-Petrovic, VM Van Deerlin… - Acta neuropathologica …, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease.
Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly …

Medicinal chemistry perspective on targeting mono-ADP-ribosylating PARPs with small molecules

MG Nizi, MM Maksimainen, L Lehtio… - Journal of Medicinal …, 2022 - ACS Publications
Major advances have recently defined functions for human mono-ADP-ribosylating PARP
enzymes (mono-ARTs), also opening up potential applications for targeting them to treat …

Poly (ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-κB upon TLR4 stimulation

M Zerfaoui, Y Errami, AS Naura, Y Suzuki… - The Journal of …, 2010 - journals.aai.org
The role of NF-κB in the expression of inflammatory genes and its participation in the overall
inflammatory process of chronic diseases and acute tissue injury are well established. We …

Poly (ADP-ribose) polymerase 1 (PARP-1) and postischemic brain damage

F Moroni - Current opinion in pharmacology, 2008 - Elsevier
Poly (ADP-ribose) polymerases (PARPs) are enzymes that are able to catalyze the transfer
of ADP-ribose units from NAD to substrate proteins and are particularly abundant in cell …

Nuclear poly (ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction

G Cipriani, E Rapizzi, A Vannacci, R Rizzuto… - Journal of Biological …, 2005 - ASBMB
To obtain further information on time course and mechanisms of cell death after poly (ADP-
ribose) polymerase-1 (PARP-1) hyperactivation, we used HeLa cells exposed for 1 h to the …

Chemical regulation of epigenetic modifications: opportunities for new cancer therapy

YG Zheng, J Wu, Z Chen… - Medicinal research …, 2008 - Wiley Online Library
Epigenetics is concerned about heritable changes in gene expression without alteration of
the coding sequence. Epigenetic modification of chromatin includes methylation of genomic …

Modulation of poly (ADP-ribosylation) in apoptotic cells

AI Scovassi, M Diederich - Biochemical pharmacology, 2004 - Elsevier
Poly (ADP-ribosylation) is a post-translational modification of proteins playing a crucial role
in DNA repair, replication, transcription and cell death. In this paper, the main features of this …